2014 Volume 60 Issue 1 Pages 82-85
Metastatic neoplasms in the larynx from remote primary tumors are uncommon, and laryngeal metastasis originating from the colorectum is extremely rare. We herein report a case of metastatic laryngeal carcinoma originating from sigmoid colon cancer in a 54-year-old female. Curative partial laryngectomy was performed, and the patient remains alive with a good quality of life and no signs of recurrence seven years and eight months after sigmoidectomy and four years and eight months after partial laryngectomy.
Secondary laryngeal cancers are very rare tumors, with an incidence ranging from 0.09% to 0.4% of all laryngeal neoplasms. Among these lesions, skin melanoma and renal cell carcinoma are the most frequent sites of origin1). However, colorectal carcinoma (CRC) metastases to the larynx are extremely rare; there are only 12 cases of secondary laryngeal tumors originating from CRC.
We herein report a case of sigmoid colon cancer metastasis to the lungs and larynx that was successfully resected and discuss the characteristics of metastatic laryngeal tumors. To our knowledge, this case is the only reported case of long-term survival in a patient with this disease.
In November 2005, a 54-year-old Japanese female underwent sigmoidectomy with lymph node dissection under a diagnosis of sigmoid colon cancer. The postoperative TNM classification was Stage IIIB disease (T3N1M0) and histopathological findings were moderately differentiated adenocarcinoma (Fig. 1a). Postoperative adjuvant FOLFOX4 (oxaliplatin plus an infusion of 5-fluorouracil /levofolinate) therapy was administered for 11 cycles. In May 2008, a computed tomography (CT) scan of the thorax showed a 2 cm nodular mass in the right middle lung. Consistent with the CT findings, positron emission tomography (PET) demonstrated high uptake of FDG in the right middle lung. There were no abnormal areas of uptake in either the anastomotic lesion or regional lymph nodes. Therefore, middle lobectomy of the right lung was performed under a diagnosis of lung metastasis. The histopathological findings were well differentiated adenocarcinoma, consistent with a diagnosis of metachronous lung metastasis of sigmoid colon carcinoma (Fig. 1b).
In November 2008, the patient was admitted to our clinic with a 2-week history of hoarseness. On admission, she looked well. Her body temperature, arterial blood pressure and respirations were normal. A physical examination showed no abnormal findings. Laboratory tests were normal, and the carcinoembryonic antigen level was 2.9 μg/L (normal range: <5.0 μg/L).
Laryngoscopy revealed a nodular mass in the right subglottic lesion (Fig. 2). A histological examination of laryngoscopic biopsy specimens revealed suspected metastasis from sigmoidal adenocarcinoma. A further workup did not reveal any other sites of metastatic spread. Therefore, the patient underwent partial laryngectomy at another institution. The pathological specimen exhibited moderately differentiated adenocarcinoma, consistent with a diagnosis of metastasis from sigmoidal adenocarcinoma (Fig. 1c). Additional chemotherapy with S1 was administered at 100 mg/day over six months. The patient remains alive with a good quality of life at seven years and six months after the initial surgery, and four years and six months after partial laryngectomy, respectively. Moreover, posttreatment annual CT scan showed no recurrent disease.
Microscopic findings of the reseted specimens. a. sigmoid colon, b. lungs, c. laryngeal tumor (H&E, a-c ×10).
Colorectal cancer is a major cause of death worldwide, and its incidence has been increasing over the past 25 years2-4).
With the increasing use of new radiologic modalities, such as CT, magnetic resonance imaging (MRI) and PET, together with the increasing survival rates of patients with primary colorectal cancer, metastasis is more likely to be diagnosed.
Common metastatic sites for adenocarcinoma of the colon and rectum include the liver and the lungs, whereas metastasis to the larynx is very rare. Metastatic neoplasms in the larynx are unusual, accounting for 0.09% to 0.4% of all laryngeal tumors1). On the other hand, Friedmann and Osborn5) reported that 23.9% of patients with metastasis to the head and neck have laryngeal and/or tracheal diseases at autopsy. The difference in the frequency of this disease in clinical and autopsy cases suggests the possibility that the actual clinical prevalence of laryngeal metastasis has been underestimated.
To the best of our knowledge, only 12 cases, including our case, of metastasis of CRC have been reported in the English language literature (Table 1)6-15).
Based on the cases with available information, laryngeal metastases have the following characteristics. The mean age of the patients with laryngeal metastasis originating from CRC was 64.7 years (range: 51-81). The 12 reported cases involved 8 females and 4 males. The signs and symptoms of secondary laryngeal neoplasms are similar to those of other malignant laryngeal lesions. The primary site of CRC was the sigmoid colon in 4 cases, rectum in 4 cases, transverse colon in 1 case and unspecified colonic locations in 3 cases. Data for the grading of primary CRC are available for 10 patients: G2 in 8 cases and G1 in 2 cases. Data for other sites of distant metastasis are available for 10 patients: 9 patients had other sites of distant metastasis and 1 patient had isolated laryngeal metastasis. Of the 9 patients with other distant sites of metastasis, metachronous lung metastasis was present in 8 cases and liver metastasis was present in 3 cases before laryngeal metastasis. Although the metastatic mechanism to the larynx is still unknown, metastatic spread can occur via hematogenous and lymphatic route. The route for hematogenous spread via the systemic circulation is the inferior vena cava, right heart, lungs, left heart, aorta, external carotid artery, upper thyroid artery, and upper laryngeal artery16). The vertebral venous plexus has also been implicated in retrograde metastatic spread of colorectal cancer17). The high incidence of lung metastasis in the patients with laryngeal metastasis strongly suggests a metastatic route from the lungs to the larynx.
Since no general rules can be established on how to treat secondary laryngeal tumors due to their rare nature, the treatment approach must be tailored to the individual patient based on the biologic behavior of the primary tumor, the characteristics of the laryngeal lesion, the general condition of the patient and the results of the metastatic workup, which must include CT, PET and bone scintigraphy as long as possible.
A general recommendation, however, can be made that symptomatic and palliative treatment should be administered in patients with multiple metastases, including those in the larynx. Options for intervention include bronchoscopy, direct laryngoscopy with laser excision, and debulking of the laryngeal tumor. Tracheostomy can be performed in patients with significant respiratory distress due to airway obstruction. A reasonable chance for curative treatment can be expected only in patients with solitary laryngeal metastases. Therefore, adjuvant therapy was done only in our present case. The prognosis of patients with laryngeal metastasis is poor because laryngeal involvement is generally observed in terminal patients with other multiple metastases. The longest survival after treatment for laryngeal metastases originating from CRC was observed in our patient. Curative treatment for laryngeal metastasis of primary CRC with an appropriate adjuvant chemotherapy may prolong the survival of carefully selected patients.
Reported cases of laryngeal metastasis originating from colorectal cancer.
a S, sigmoid colon; R, rectum; T, transeverse colon.
While the incidence is low, patients with a history of CRC, lung metastasis and symptoms of hoarseness, dyspnea, dysphonia, and stridor should be evaluated for the possibility of metastasis to the larynx.
A thorough investigation for metastasis to other organs should also be performed.
S. Terashima and other co-authors have no conflict of interest.